Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern Medicine | Strategic Alliance Partners

January 30, 2024

Hematologist-oncologists discuss the risk stratification of patients with myelodysplastic syndromes and how patient risk status determines prognosis.

January 30, 2024

A panel of experts on myelodysplastic syndromes (MDS) introduce themselves and provide an overview of diagnosis practices, highlighting common symptoms and the typical patient presentation.

January 19, 2024

State of the Science Summit - Lung Cancer: Chaired by Nisha A. Mohindra, MD

January 04, 2024

Dr Gradishar discusses the FDA approval of capivasertib plus fulvestrant for patients with advanced HR-positive, HER2-negative breast cancer harboring PIK3CA, AKT1, or PTEN alterations.

December 21, 2023

The transmembrane protein B7-H4 has emerged as an interesting therapeutic target in multiple solid tumors, with investigators mostly focusing on the development of antibody-drug conjugates aimed at the pathway.

December 11, 2023

A new artificial intelligence tool may make it possible to spare breast cancer patients unnecessary chemotherapy treatments by using a more precise method of predicting their outcomes.

December 08, 2023

Seema A. Khan, MD, discusses 5-year clinical outcomes from the ECOG-ACRIN E4112 trial, which is evaluating the use of MRI and a 12-gene expression assay to optimize local therapy for patients with ductal carcinoma in situ.

October 06, 2023

Priya U. Kumthekar, MD, details the specialized program for fellows while reflecting on her own experiences, highlights her research in brain metastases, and offers advice to both fellowship directors and current fellows in oncology.

September 05, 2023

The Northwestern Medicine Canning Thoracic Institute Hispanic Program was recently launched to offer personalized care for lung and thoracic patients in their native language, making life-saving care more accessible for the Hispanic community and people who prefer to speak Spanish by removing cultural and linguistic barriers.

August 02, 2023

Scientists develop ‘QR code for cancer cells,’ like tagging swans in a pond.

May 25, 2023

Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate large, critical regions of the human brain to deliver chemotherapy that was injected intravenously.

May 24, 2023

A panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.

May 23, 2023

For the second time at Northwestern Medicine, surgeons have successfully performed a double-lung transplant on a patient with stage 4 lung cancer who was being considered for hospice.

May 17, 2023

An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.

May 17, 2023

A comprehensive overview of treatment approaches for patients with high-risk melanoma.

May 10, 2023

Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.

May 10, 2023

A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.

May 03, 2023

An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.

May 03, 2023

Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.

April 26, 2023

Expert oncologists look to the future of treatment for cutaneous squamous cell carcinoma.